Introduction
Muscular dystrophy has been noted on progressive and degenerative diseases due to the degeneration of skeletal muscles, and it is also a debilitating X-linked disease with limited treatment options [23]. Until now many different genes have been linked with muscular dystrophy [5]. Mutations of the dystrophin-glycoprotein complex (DGC) cause autosomally inherited muscular dystrophy, indicating the importance of this complex in the maintaining normal muscle architectures. The lack of those proteins cause membrane destabilization and the activation of multiple pathological cellular cascades, most likely intracellular Ca2+ ion accumulation, which further leads to cellular degeneration, apoptosis, and necrosis resulting in the replacement of muscle parenchyma by adipose tissue and connective tissue, finally completion of muscular fibrosis.
Muscular dystrophin related diseases can occur and are reported worldwide. Its incidence varies, as some forms are more common than others. Its most common form in children is Duchenne and Becker muscular dystrophy as it affects approximately 1.38 in every 10,000 males 5 through 24 years of age [24]. The muscle fiber membrane contains a group of proteins called the dystrophin-glycoprotein complex which prevents damage as muscle fibers contract and relax [4]. Loss of the dystrophin-glycoprotein complex (DGC) or a subset of its components can lead to muscular dystrophy. However, the patterns of symptoms differ depending on which proteins are affected. The absence of dystrophin leads to loss of the entire dystrophin glycoprotein complex and is associated with susceptibility to contractile injury. In contrast, muscles lacking gamma-sarcoglycan (gamma-SG) display little mechanical fragility and still develop severe pathology [4]. Once the muscle fiber membrane is damaged, it begins to leak the muscle protein creatine kinase, which is needed for the chemical reactions that produce energy for muscle contractions and uptake on excess calcium, which causes further muscular damage [4].
Although affecting several tissues and very likely all organs, it most prominently affects the integrity of muscle fibers. Individuals affecting muscular dystrophy could not control muscle strength and tendon reflexes due to the loss and replacement of muscle parenchyma with connective tissues by fatty change, inflammation and fibrosis [2, 4, 15].
Among muscular dystrophies, Duchenne type is most common as it accounts for approximately 50 percent of all clinical cases [2, 4, 12, 20, 27]. Progressive weakness and muscle wasting caused by degenerating muscle fibers begins in the upper legs and pelvis before spreading into the upper arms. The wasting muscles, in particular the calf and deltoid muscles might be enlarged by an accumulation of fat and connective tissue, causing them to look larger and healthier called pseudohypertrophy. As the disease progresses, the muscles in the diaphragm that assist in breathing and coughing might show progressive weakness. Patients may experience breathing problem and respiratory infections. Bone thinning and scoliosis are also commonly observed symptoms [2, 4, 12, 20, 27].
Therefore, Duchenne muscular dystrophy (DMD), the most common form of muscle-wasting diseases in childhood, has been studied intensively since the dystrophin protein was identified. The most significant obstacle in development of an effective treatment is the large size of the dystrophin gene because its cDNA is 14 kb [20].
Recently, systemic corticosteroids treatment, exon skipping, nonsense suppression, viral gene therapy and utrophin modulation have been applied to cure DMD [10, 28], but those cannot be a perfect remedy yet.
Even though lots of researchers have attempted to develop a method of intervention in muscular dystrophy, so far, animal disease models for human are limited and need to be developed and intensively researched. So far, muscular dystrophy naturally occurred in skeletal muscles of large animals such as cow, horse and other wild lives have not been studied much and therefore this work focused on muscle biopsies using bovine skeletal muscles to give valuable information which would be applicable to human beings in the near future.
Especially, two different breeding conditions were used comparing mainly grass-fed freely moving cows in Australia versus mainly grain-fed cows limited free movement due to the narrow space of an cattle shed in Korea.
This study aims not only to reveal the correlation between the lipid infiltration and dystrophin constitutions to develop pathological protein markers for early proteolytic processes, but also to identify the effects that breeding environment and diet have on skeletal muscular architectures.
Materials and Methods
Specimens information
Australian cattle used in this experiment were raised in area of near Brisbane, Queensland of Australia. That area is located at South 27′ 23″ latitude and East 153’ 07’’ longitude. Based on average climatological data of this area collected for the past 43 years from www.weatherbase.com, yearly average temperature is 20℃ with fluctuation between 15℃ and 25℃. Those cattle were raised in grassland at pasture. Experimental samples were collected from the same, designated part of frozen Australian cattle skeletal muscles. The Australian cattle were mainly fed with the grass such as Black spear grass (Heteropogon contortus), Queensland blue grass (Dichanthium insculptum, Dichanthium sericeum), Australia native sorghum, Rhodes grass (Chloris gayana), Pangola (Digitaria decumbens), and Kikuya (Pennisetum clandestinum). Grass and water were ad libitum without a restraint in movement. Breed of the cattle was Charolais.
Meanwhile, Korean cattle used in this experiment were raised in an area near Daegu, Kyungpook of Korea. That area is located at North 35′ 52″ latitude and East 128′ 37″ longitude. Based on average climatological data of this area collected for the past 85 years from www.weatherbase.com, yearly average temperature is 12℃ with fluctuation between -1℃ and 26℃. Those cattle were raised in the relatively narrow and limited space of a cow house. Experimental samples were collected from the same, designated part of Korean cattle skeletal muscle under 4℃. The Korean cattle were mainly fed a grain diet and the different diet sources of 5 grain meals are corn, wheat, soybean meal, wheat bran and coconut oil meal. Breed of the cattle was Korean Native cattle.
Total skeletal muscle specimens from 244 cattle were collected. Among them, 126 specimens were from Koryung slaughter house in Korea and they were immediately fixed at the 10% neutral formalin. In another set of collected specimens, 118 specimens were from Imported Australian cattle (Angus, Hereford, Charolais). This group was also fixed at the 10% neutral formalin for histopathology and immunohistochemical analysis. Exactly the same area was biopsied from both countries from M. Serratus Ventralis (collected from ′chuck roll′) and M. Latissimus Dorsi (collected from ′short rib′).
Histopathology
Tissue samples from the skeletal muscles of both Korean native cattle and imported Australian cattle were rapidly removed and fixed in 10% neutral buffered formalin, processed routinely and embedded in paraffin wax. Sections were cut to 4-6 μm in thickness. The sections were stained with hematoxylin and eosin (H-E).
Immunohistochemistry
For immunohistochemistry, sections of tissue were deparaffinized in xylene, and rehydrated in a graded alcohol series and endogenous peroxidase activity was inhibited using 3% hydrogen peroxide for 40 min and executed a microwave antigen process in 10 mmol/l citrate and proteinase K and incubated in a solution of 3% hydrogen peroxide in methanol for 30 min and microwaved at 750 W for 10 min in 10 mmol/l citrate buffer, pH 6.0. Slides were washed with PBS, and then immunostained with primary antibodies from the mouse monoclonal antibodies. The antibodies used for immunostaining were as follows: Dystrophin (Novocastra, Laboratories, New Castle Upon Tyne, UK), α- dystroglycan (Upstate cell signaling solution, Lake Placid, New York), β-dystroglycan (Novocastra, Laboratories, New Castle Upon Tyne, UK), Dysferin (Novocastra, Laboratories, New Castle Upon Tyne, UK), Caveolin-3 (Transduction laboratories, Lexington, Kentucky, USA), CD36 (Cascade Bioscience, Winchester, MA, USA). The antigen-antibody complex was visualized by using an Histostain-plus Bulk kit (Zymed Laboratories Inc., San Francisco, CA, USA) with 3,3-diamino benzidine (DAB, Zymed Laboratories Inc., San Francisco, CA, USA). Slides were then rinsed in distilled water and counterstained with Mayers hematoxylin. For negative control, the primary antibody was replaced by normal mouse IgG.
Statistical analysis
All values are expressed as means ± SD. Statistical analyses were performed using the Student′s t-test. Statistical significance was assumed when p<0.05.
Results
Histopathology
At microscopic examination in H&E stain, although there were no specific lesions, fat infiltration was mainly observed replacing skeletal muscle cells in Korean cattle (Fig. 1A-B). As the result of grading the degree of fat infiltration, 34 of the 126 samples showed fat infiltrations in skeletal muscles of Korean cattle. Therefore, 27% of skeletal muscles were appeared with fat infiltration in Korean cattle (Fig. 1D) however, there was only one of the 118 samples fat infiltrations in Australian cattle observed (Fig. 1E). Skeletal muscles of Australian cattle showed freezing injury such as shrunken myofibers by freezing and thawing process (Fig. 1C), indicating physical myofiber damages.
Fig. 1.Histopathological findings in skeletal muscles of Korea Native cattle (A, B, D) vs. Australian cattle (C, E). A: Skeletal muscles of Korean Native cattle showed normal architecture. B: Fat infiltrated into parenchyma and replaced skeletal muscle cells of Korean Native cattle. C: Skeletal muscles of Australian cattle showed normal architecture although they showed freezing injury such as shrunken myofibers by physical freezing and thawing process. H&E. Original magnifications: ×50 (A-C), ×200 (insets of A-C) D: Fat infiltration rate in skeletal muscle of Korean Native cattle. 34 of the 126 samples showed fat infiltrations in skeletal muscles. Therefore, 27% of skeletal muscles appeared with fat infiltration in Korean Native cattle. E: Fat infiltration rate in skeletal muscle of Australian cattle. Fat infiltration was observed in only one of the 118 samples in Australian cattle.
Immunohistochemistry
For the immunoistochemical analysis of dystrophin in cattle skeletal muscles, we randomly selected 10 specimens respectively from both normal and fat infiltrated muscles and immunohistochemistry for dystrophin was executed. Dystrophin is a subsarcolemmal actin-binding protein, it ensures a link between the actin cytoskeleton and the extracellular matrix with glycoprotein complex [9]. Normal muscle of Korean native cattle showed normal sarcolemmal localization for dystrophin. However, fat infiltrated muscles showed a deficiency of dystrophin staining. Dystrophin staining appeared clearly and abundantly on sarcolemma of normal muscle, however, sarcolemma of fat infiltrated muscles showed dystrophin stainining non-continuously and faintly (Fig. 2A-B). Dystrophin expression significantly decreased in fat infiltrated muscles (Fig. 2D). In correlation analysis, it is observed that increase of fat infiltration grade decreases the dystrophin expression by acceleration of dystrophin protein degredation (Fig. 3).
Fig. 2.Immunohistochemical analysis of dystrophin in skeletal muscles of Korean Native cattle vs. Australian cattle. A: Normal muscle of Korean Native cattle showed normal sarcolemmal localization for dystrophin. B: Fat infiltrated muscles of Korean Native cattle showed a deficiency of dystrophin staining non-continuously and faintly. C: Normal muscle of Australian cattle showed general decrease of dystrophin expression due to freezing-thawing damage. Immunostaining for dystrophin (A-C), Original magnifications: ×50(A-C), ×200 (insets of A-C) D: Expression of Dystrophin in skeletal muscles of Korean Native cattle. Dystrophin expression significantly decreased in fat infiltrated muscles. *: p<0.05 compared with normal muscles. E: Expression of dystrophin in skeletal muscles of Australian cattle. Only 3 of the 20 species expressed dystrophin faintly.
Fig. 3.Correlation analysis between dystrophin expression and fat infiltration in randomly selected ten muscle specimens of Korean Native cattle. It is observed that an individual showing the increase of fat infiltration grade also displayed decreased dystrophin expression. Pearson′s correlation coefficient r=-0.609, p=0.031
In Australian cattle, they showed a general decrease of dystrophin expression (Fig. 2C). It might be due to the specimens of Australian cattle were only received 5 months since slaughter, therefore dystrophin may have been destroyed gradually over a long time (Fig. 2E).
For the immunihistochemical analysis of CD36 in cattle skeletal muscles, we randomly selected 10 specimens respectively from both normal and fat infiltrated muscles and executed immunohistochemistry for CD36. CD36 is a human leukocyte differentiation factor and it is highly homologous to the 88 kDa integral membrane protein fatty acid translocase (FAT), therefore, CD36 antibody is used to detect FAT [9]. CD36 antibody has been reported to express in the small capillaries, representing the presence of FAT in vascular endothelium, however, the cascade bioscience CD36 antibody revealed a strong intracellular signal in fibers indentified by myosin heavy chain 1 (MCH1) staining [9]. Therefore CD36 positive vascular endothelium was regarded without positive myofibres in immunohistochemical analysis. In this experiment, CD36 expression was observed abundantly in fatty infiltrated muscles and its expression increased significantly in fatty infiltrated muscles (Fig. 4A-C).
Fig. 4.Immunohistochemical analysis of CD36 in skeletal muscles of Korean native cattle. CD36 antibody express in the small capillaries, representing the presence of FAT in vascular endothelium. A: Some capillaries expressed CD36 in normal muscles. B: CD36 expression was observed abundantly in fatty infiltrated muscles. Immunostaining for CD36 (A-B), Original magnifications: ×50 (A-B), ×400(insets of A-B). C: Morphometrically, CD36 expression increased significantly in fatty infiltrated muscles.
For the immunihistochemical analysis of α-dystroglycan in cattle skeletal muscles, we randomly selected 5 specimens respectively from both normal and fat infiltrated muscles and executed immunohistochemistry for α-dystroglycan. α-dystroglycan expressed normally at sarcolemma of skeletal muscles. In this experiment, the amount of expression was very low, irrespective of normal and fat infiltrated muscles (Fig. 5A-C).
Fig. 5.A-B. Immunohistochemical analyses of α-dystroglycan (A-C), β-dystroglycan (D-F), caveolin-3 (G-I) and dysferin (J-L) in skeletal muscles of Korean Native cattle. The left figures (A, D, G, J) are the representative images of normal muscle, and the right figures (B, E, H, K) are their fat infiltrated counterpart. A-C: α-dystroglycan normally expressed on sarcolemma, the amount of expression was very low irrespective of normal and fat infiltrated muscles. Immunostaining for α-dystroglycan (A-B), Original magnifications: ×50(A-B), ×200(insets of A-B). There was no observed difference of expression between normal and fat infiltrated muscles due to general low expression. D-F: Normal muscles showed normal sarcolemmal localization for β -dystroglycan. Fat infiltrated muscles showed slight decrease of β-dystroglycan expression, but there was no significance. Immunostaining for β-dystroglycan (D-E), Original magnifications: ×50(D-E), ×200(insets of D-E). β-dystroglycan expression decreased slightly more in fat infiltrated muscles than normal muscles, but there was no significant difference. G-I: Caveolin-3 expressed normally at sarcolemma of skeletal muscles. The sarcolemma expressed caveolin-3 irrespective of normal and fat infiltrated muscles. Immunostaining for caveolin-3 (G-H), Original magnifications: ×50(G-H), ×200(insets of G-H). There was no observed difference of expression between normal and fat infiltrated muscles because of caveolin-3 expression in sarcolemma. J-L: Dysferin expressed normally at sarcolemma of skeletal muscles. The sarcolemma expressed dysferin irrespective of normal and fat infiltrated muscles. Immunostaining for dysferin (J-K), Original magnifications: ×50(J-K), ×200(insets of J-K). There was no observed difference of expression between normal and fat infiltrated muscles because dysferin expression was almost observed in sarcolemma.
For the immunihistochemical analysis of β-dystroglycan in cattle skeletal muscles, we randomly selected 10 specimens respectively from both normal and fat infiltrated muscles and executed immunohistochemistry for β-dystroglycan. Dystroglycan is a non-integrin adhesion molecule and pivotal component of the dystrophin-glycoprotein complex associated with the cytoskeleton composed of two subunits, α and β [9]. β-dystroglycan expressed normally at sarcolemma of skeletal muscles. In this experiment, normal muscles of Korean native cattle showed normal sarcolemmal localization for β-dystrogly can and fat infiltrated muscles showed mild decrease of β-dystroglycan expression, but there was no significant difference (Fig. 5D-F)
For the immunihistochemical analysis of caveolin-3 in cattle skeletal muscles, we randomly selected 10 specimens respectively from both normal and fat infiltrated muscles and executed immunohistochemistry for caveolin-3. Caveolin-3 is the principal structure protein of caveolar membrane domains in skeletal muscle cell type and localized to the sarcolemma. In this experiment, the sarcolemma expressed caveolin-3 irrespective of normal and fat infiltrated muscles (Fig. 5G-I).
For the immunihistochemical analysis of dysferin in cattle skeletal muscles, we randomly selected 10 specimens respectively from both normal and fat infiltrated muscles and executed immunohistochemistry for dysferin. Dysferin is not an integral component of the dystrophin-glycoprotein complex, but it is suggested that dysferin has a direct or indirect functional association with the dystrophin-glycoprotein complex [3]. Dysferin expressed normally at sarcolemma of skeletal muscles. In this experiment, sarcolemma expressed dysferin irrespective of normal and fat infiltrated muscles (Fig. 5J-L).
Discussion
Diverse animal models for human muscular diseases have been intensively studied for developing new therapeutic technologies including gene therapy and stem cell therapy in muscular dystrophy. So far, there are lots of studies using small animal model such as mice, but very limited studies for intervention have been reported due to the shortage of large animal models. Excluding rodents, an animal model specifically reproducing the alterations in the dystrophin gene and the full spectrum of human pathology has been reported in only golden retriever dogs, showing a single mutation in intron 6, resulting in complete absence of the dystrophin protein, and early and severe muscle degeneration with nearly complete loss of motility and walking ability [25].
In this study, the muscular dystrophin protein levels of Korean cattle, which bred in limited environment and grain fed condition, versus Australian cattle, which freely bred on the grass and ad libitum grass fed, were surveyed. This was done to investigate whether industrial animals can be utilized as large animal models for muscle dystrophy and also analyze the effect of breeding conditions on muscularity as comparing stress conditions and freely movable conditions without control.
Clinically, sensitive indicators of the damage to muscular architecture were the enzymes aspartate aminotransferase (AST), alanine aminotransferase (ALT), and mainly creatine kinase (CK): the activities of these enzymes increased significantly after the heifers had been driven to pasture. Some reported that nutritional supplements such as vitamin E and selenium can be use to block any leakage of muscle break down enzymes [14]. However, these serological markers are applicable only when animals are alive. Therefore, new histological markers, which can be applicable on meat status, are required with consideration of practicality of large animals as muscle dystrophy models. There have been several researches related with large animals and muscular degeneration on histopathology, and these gave a clue to find the new histological markers.
In one case of bovine fetus, lipomatous masses were present within the cervical vertebral canal, compressing the spinal cord. Microscopically, the prominent muscular enlargement was result from massive adipose and fibrous connective tissue accumulation which are substituting atrophic muscles [17].
Meanwhile, two Japanese Black bull calves from a dam showed muscular weakness and became recumbent after birth. At necropsy, skeletal muscles, including face, neck, body and proximal and distal forelimb and hind limb were extremely pale in color and edematous. Histopathological examination of skeletal muscles revealed degenerative changes as follows: replacement of muscle with fat, variation in muscle fiber diameter, internal nuclei, central core-like structures, and vacuolar and hyaline degeneration of muscle fibers. Those symptoms were all common histological abnormalities shown in muscular dystrophy, and these cases seem to be classified as congenital myopathy based on pathological alterations and age of onset [30].
There is also an unusual congenial nutritional muscular dystrophy case in a newborn calf. A 13-hour-old Aberdeen-Angus was involuntarily recumbent since birth. It showed increased serum creatine kinase, and decreased serum vitamin E and selenium levels. Recovery followed after supportive therapy and parenteral vitamin E and selenium. [1].
Generally, dystrophin, a cytoskeletal actin-binding protein, is a relevant in situ marker for muscular proteolysis, the immunodetection of dystrophin can allow the monitoring of early proteolysis. Using anti-dystrophin antibodies di-rected toward the carboxy-terminal region, a highly sensitive domain exposed to calpain activity, it was shown that proteolysis kinetics were strongly influenced by the muscular lipid contents and also coincided with degradation of muscular dystrophin protein. This data was also matched with former reports regarding that muscular proteolysis was accelerated during the first 8 hours of storage at 0℃ with the high-fat diet when comparing low-fat diets as a caloric proportion of 11.3% lipid and high-fat diets as caloric proportion of 30% lipid [6]. This faster proteolysis is possibly due to the activation or translocation of calpains, related to lipid accumulation in muscle fibers and cytoskeleton alterations [6].
In case of dystrophin deficiency, which is well-established in mdx mice, hind limb muscles of mdx mice undergo necrosis at the time of weaning when the motor activity of the mice greatly increases and muscle energy metabolism becomes more dependent on insulin and carbohydrates [19, 29]. Null mutation of any one of several members of the dystrophin protein complex can cause progressive, and possibly fatal, muscle wasting. Although these muscular dystrophies arise from the mutation of a single gene that is expressed primarily in muscle, the resulting pathology is complex and multi-systemic, which shows a broader disruption of homeostasis than would be predicted by deletion of a single- gene product.
Current evidence indicates three general routes through which free radical production can be disrupted in dystrophin deficiency to contribute to the ensuing pathology. The specific disruptions of free radicals that underlie major features of muscular dystrophy have been reported to develop more targeted and successful therapeutic approaches [26].
Duchenne muscular dystrophy is a progressive muscle-wasting disease resulting from lack of the sarcolemmal protein dystrophin. However, the mechanism leading to this becoming fatal is not fully understood. Several lines of evidence suggest a role for nuclear factor (NF)-kappa B in muscle degeneration as well as regeneration in DMD patients and mdx mice via inhibition experiments by using lipid peroxidation inhibitor IRFI-042 treatment [31]. Increased forelimb strength normalized to weight and decreased fatigue reported. Reduced serum creatine kinase level also reported, indicating that oxidative stress/lipid peroxidation might be represented as one of the mechanisms activating NF-kappa B and the consequent pathogenetic cascade in mdx mice [18].
Due to dystrophin, playing a key role for in a cytoskeletal cellular function at the inner surface of skeletal and cardiac muscle fibers, MAPK kinase signalling pathway has been much focused on and studied in diaphragm muscle fibers from dystrophin-deficient mdx mice. Activation of extracellular signal-regulated kinase 1/2 (ERK1/2) but not c-Jun N-terminal kinase-1 or p38 MAP kinase has been noted in the mdx muscle [16]. High fat diet during the farming has also been reported as a faster proteolytic factor, possibly by activation of calpain-related lipid accumulation in muscle fibers with cytoskeletal alterations [6].
These reports were also highly correlated with lipid infiltration and dystrophin degradation in both Korean cattle and Australian cattle, indicating fed diets and environmental atmosphere might be associated with stress condition such as production of free radicals and accumulation of intracellular Ca2+ ions, those are all related with cellular damages and degeneration. These cascades recruit inflammatory events and finally replace muscle parenchyma with connective tissues. Stress, high muscular activity and hypoxia were described to increase muscular ischemia [11], and higher level of muscular fatty change observed in Korean cattle might be ascribed to its confined breeding condition.
Meanwhile, CD36 is unique and highly expressed both in adipocytes and mammary gland secretory epithelial cells, those are actively involved in fatty acid uptake with synthesis, storage and secretion of triacylglycerol [13]. CD36 is an important regulator of lipid metabolism in vivo due to its role in the facilitated uptake of long-chain fatty acids. Tissues such as muscle, which normally express high levels of CD36, shift to high glucose utilization in CD36 deficiency, are possibly involved with peroxisome-proliferator-activated receptor (PPAR) mediated fatty acids metabolism [7]. Currently the adipogenetic involvement through the peroxisome-proliferator-activated receptor γ (PPARγ) is being intensively studied by using primary mesenchymal stem cells derived from adipose tissues. Especially, peroxisome-proliferator-activated receptor γ (PPARγ) agonists might be associated with activation of myoblast and chondrogensis, skipping adipogenesis. For that reason, peroxisome-proliferator-activated receptor γ (PPARγ) agonists regulated protein levels via two-dimensional gel elctrophoresis are being searched for. At the stage of stress condition induced by carbon tetrachloride treatment, hepatic stellate cells, which are responsible for making connective tissues that leads to fibrosis and further fatal organ dysfunction, got contain lipid accumulation. Simultaneously, upregulation of peroxisome-proliferator-activated receptor γ was identified in protein levels, indicating the involvement of adipogenesis [22]. So here it can be assumed to have a strong involvement of peroxisome-proliferator-activated receptor γ for lipid accumulation on diverse organs such as the liver and muscles. Among many organs, peripheral muscles are the major target for glucose uptake for utilization. So muscles are much more interesting target tissue for lipid infiltration to see regulation of adipogenesis via peroxisome-proliferator-activated receptor γ.
Fatty infiltration is highly correlated with dystrophin protein degradation based on the present study. There are similar literatures reporting fatty acid composition and cholesterol contents of muscle and adipose tissue from mature cattle [8]. Also, the effect of stress on tissue alpha-tocopherol was investigated in fed a corn/corn silage-based diet in the presence and absence of supplemental vitamin E. According to the data, the stress increased serum cortisol, creatine kinase, and urea and supplemental vitamin E reduced the creatine kinase relative to those not supplemented with vitamin E [21].
In the present study, dystrophin was significantly reduced in the group of fatty infiltration skeletal muscle and this reduction was highly correlated with the fatty infiltration in skelatal muscles. CD36, which is known as a fat transporter, is more highly expressed in the fat infiltration skeletal muscle cells, indicating that fatty acid involves in inhibition of dystrophin protein expression. Various breeding factors such as oxidative stress, oxidized lipid from the diets and environmental factors such as exercise, temperature and amount of free time spent might be critical points affecting skeletal muscular architectures and cytoskeletal proteins.
Taken together, dystrophin is the most sensitive membrane protein involving muscular dystrophy and muscular degeneration. Therapeutic approaches can be applied in terms of three potential goals: improvement of dystrophic phenotype; expression of dystrophin; and overexpression of utrophin, because utrophin exhibits 80% homology with dystrophin and is able to perform similar functions. Pharmacological strategies designed to overexpress utrophin appear promising and may circumvent many obstacles to gene and cell-based therapies.
Besides, the histopathological markers such as CD36 can be newly applied to the study of muscular dystrophy in humans and pathogenesis of muscular diseases in animal models in the future and the data were also very informative in the attempts to extend muscular diseases pathogenesis, intervention, and therapeutic approaches by suggesting new potentiality of industrial animals as spontaneous occurring large animal models for muscular dystrophy.
참고문헌
- Abutarbush, S. M. and Radostits, O. M. 2003. Congenital nutritional muscular dystrophy in a beef calf. Can. Vet. J. 44, 738-739.
- Al-Ruwaishid, A., Vajsar, J., Tein, I., Benson, L. and Jay, V. 2003. Centronuclear myopathy and cardiomyopathy requiring heart transplant. Brain Dev. 25, 62-66. https://doi.org/10.1016/s0387-7604(02)00151-1
- Bansal, D. and Campbell, K. P. 2004. Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol. 14, 206-213. https://doi.org/10.1016/j.tcb.2004.03.001
- Barton, E. R. 2006. Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle. Am. J. Physiol. Cell. Physiol. 290, C411-9.
- Blake, D. J., Weir, A., Newey, S. E. and Davies, K. E. 2002. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 82, 291-329. https://doi.org/10.1152/physrev.00028.2001
- Bonnal, C., Raynaud, F., Astier, C., Lebart, M. C., Marcilhac, A., Coves, D., Corraze, G., Gelineau, A., Fleurence, J., Roustan, C. and Benyamin, Y. 2001. Postmortem degradation of white fish skeletal muscle (sea bass, Dicentrarchus labrax): fat diet effects on in situ dystrophin proteolysis during the prerigor stage. Mar. Biotechnol. (NY). 3, 172-180. https://doi.org/10.1007/s101260000059
- Drover, V. A. and Abumrad, N. A. 2005. CD36-dependent fatty acid uptake regulates expression of peroxisome proliferator activated receptors. Biochem. Soc. Trans. 33, 311-315. https://doi.org/10.1042/BST0330311
- Eichhorn, J. M., Coleman, L. J., Wakayama, E. J., Blomquist, G. J., Bailey, C. M. and Jenkins, T. G. 1986. Effects of breed type and restricted versus ad libitum feeding on fatty acid composition and cholesterol content of muscle and adipose tissue from mature bovine females. J. Anim. Sci. 63, 781-794. https://doi.org/10.2527/jas1986.633781x
- Ervasti, J. M. and Campbell, K. P. 1993. Dystrophin and the membrane skeleton. Curr. Opin. Cell Biol. 5, 82-87. https://doi.org/10.1016/S0955-0674(05)80012-2
- Fairclough, R. J., Wood, M. J. and Davies, K. E. 2013. Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat. Rev. Genet. 14, 373-378. https://doi.org/10.1038/nrg3460
- Ferrari, R., Merli, E., Cicchitelli, G., Mele, D., Fucili, A. and Ceconi, C. 2004. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ann. N. Y. Acad. Sci. 1033, 79-91. https://doi.org/10.1196/annals.1320.007
- Freund, A. A., Scola, R. H., Arndt, R. C., Lorenzoni, P. J., Kay, C. K. and Werneck, L. C. 2007. Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach. Arq. Neuropsiquiatr. 65, 73-76. https://doi.org/10.1590/S0004-282X2007000100016
- Keizer, H. A., Schaart, G., Tandon, N. N., Glatz, J. F. and Luiken, J. J. 2004. Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres. Histochem. Cell Biol. 121, 101-107. https://doi.org/10.1007/s00418-003-0615-3
- Kovac, G., Mudron, P., Prosbova, M. and Pasteka, J. 1987. Clinical and biochemical response in the prevention of nutritional myodystrophy in heifers. Vet. Med. (Praha). 32, 81-92.
- Kuehn, B. M. 2007. Studies point way to new therapeutic prospects for muscular dystrophy. JAMA 298, 1385-1386.
- Kumar, A., Khandelwal, N., Malya, R., Reid, M. B. and Boriek, A. M. 2004. Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. FASEB J. 18, 102- 113. https://doi.org/10.1096/fj.03-0453com
- Langohr, I. M., Stevenson, G. W. and Valentine, B. A. 2007. Muscular pseudohypertrophy (steatosis) in a bovine fetus. J. Vet. Diagn. Invest. 19, 198-201. https://doi.org/10.1177/104063870701900212
- Messina, S., Altavilla, D., Aguennouz, M., Seminara, P., Minutoli, L., Monici, M. C., Bitto, A., Mazzeo, A., Marini, H., Squadrito, F. and Vita, G. 2006. Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am. J. Pathol. 168, 918-926. https://doi.org/10.2353/ajpath.2006.050673
- Mokhtarian, A., Lefaucheur, J. P., Even, P. C. and Sebille, A. 1995. Effects of treadmill exercise and high-fat feeding on muscle degeneration in mdx mice at the time of weaning. Clin. Sci. (Lond). 89, 447-452. https://doi.org/10.1042/cs0890447
- Muntoni, F. and Wells, D. 2007. Genetic treatments in muscular dystrophies. Curr. Opin. Neurol. 20, 590-594. https://doi.org/10.1097/WCO.0b013e3282efc157
- Nockels, C. F., Odde, K. G. and Craig, A. M. 1996. Vitamin E supplementation and stress affect tissue alpha-tocopherol content of beef heifers. J. Anim. Sci. 74, 672-677. https://doi.org/10.2527/1996.743672x
- Park, J. K., Ki, M. R., Lee, H. R., Hong, I. H., Ji, A. R., Ishigami, A., Park, S. I., Kim, J. M., Chung, H. Y., Yoo, S. E. and Jeong, K. S. 2010. Vitamin C deficiency attenuates liver fibrosis by way of up-regulated peroxisome proliferator-activated receptor-gamma expression in senescence marker protein 30 knockout mice. Hepatology 51, 1766-1777. https://doi.org/10.1002/hep.23499
- Rodino-Klapac, L. R., Chicoine, L. G., Kaspar, B. K. and Mendell, J. R. 2007. Gene therapy for duchenne muscular dystrophy: expectations and challenges. Arch. Neurol. 64, 1236-1241. https://doi.org/10.1001/archneur.64.9.1236
- Romitti, P. A., Zhu, Y., Puzhankara, S., James, K. A., Nabukera, S. K., Zamba, G. K., Ciafaloni, E., Cunniff, C., Druschel, C. M., Mathews, K. D., Matthews, D. J., Meaney, F. J., Andrews, J. G., Conway, K. M., Fox, D. J., Street, N., Adams, M. M., Bolen, J. and MD STARnet. 2015. Prevalence of Duchenne and Becker muscular dystrophies in the United States. Pediatrics 135, 513-521. https://doi.org/10.1542/peds.2014-2044
- Sampaolesi, M., Blot, S., D′Antona, G., Granger, N., Tonlorenzi, R., Innocenzi, A., Mognol, P., Thibaud, J. L., Galvez, B. G., Barthelemy, I., Perani, L., Mantero, S., Guttinger, M., Pansarasa, O., Rinaldi, C., Cusella De Angelis, M. G., Torrente, Y., Bordignon, C., Bottinelli, R. and Cossu, G. 2006. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444, 574-579. https://doi.org/10.1038/nature05282
- Tidball, J. G. and Wehling-Henricks, M. 2007. The role of free radicals in the pathophysiology of muscular dystrophy. J. Appl. Physiol. (1985). 102, 1677-1686.
- Voisin, V. and de la Porte, S. 2004. Therapeutic strategies for Duchenne and Becker dystrophies. Int. Rev. Cytol. 240, 1-30. https://doi.org/10.1016/S0074-7696(04)40001-1
- Wein, N., Alfano, L. and Flanigan, K. M. 2015. Genetics and Emerging Treatments for Duchenne and Becker Muscular Dystrophy. Pediatr. Clin. North Am. 62, 723-742. https://doi.org/10.1016/j.pcl.2015.03.008
- Wineinger, M. A., Abresch, R. T., Walsh, S. A. and Carter, G. T. 1998. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. Am. J. Phys. Med. Rehabil. 77, 20-27. https://doi.org/10.1097/00002060-199801000-00004
- Yamada, M., Takashima, H., Takizawa, T., Mizuno, K., Nakamura, K., Furuoka, H. and Masegi, T. 2004. Congenital myopathy in Japanese Black calves. J. Vet. Med. Sci. 66, 997-1001. https://doi.org/10.1292/jvms.66.997
- Zust, J., Hrovatin, B. and Simundic, B. 1996. Assessment of selenium and vitamin E deficiencies in dairy herds and clinical disease in calves. Vet. Rec. 139, 391-394. https://doi.org/10.1136/vr.139.16.391